☆ 4.7 Article

Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS- 441524 in rats

EBIOMEDICINE (2022)

Related references

Note: Only part of the references are listed.

Review Infectious Diseases

A review of remdesivir for COVID-19 in pregnancy and lactation

Sarah C. J. Jorgensen et al.

Summary: Pregnant individuals face a higher risk of severe COVID-19 complications compared to non-pregnant individuals, yet they are excluded from clinical trials, leading to knowledge gaps. Data from post-marketing studies are filling these gaps, aiding in informing clinical decisions regarding the use of remdesivir during pregnancy and lactation.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Add to Collection

Review Chemistry, Medicinal

ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential

Subrata Deb et al.

Summary: The global pandemic of COVID-19 has highlighted the importance of exploring treatment options like remdesivir, originally designed for Ebola, in combating the disease. However, limited information on the ADME, PK, and DDI of remdesivir underscores the need for further research to ensure effective treatment for patients.

PHARMACEUTICALS (2021)

Add to Collection

Article Obstetrics & Gynecology

Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study

Ipek Gurol-Urganci et al.

Summary: This study found that SARS-CoV-2 infection at the time of birth is associated with higher rates of adverse maternal and perinatal outcomes, including fetal death, preterm birth, preeclampsia, and emergency cesarean delivery. Pregnant women infected with SARS-CoV-2 should be prioritized for vaccination to reduce these risks.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action

Melanie M. Taylor et al.

Summary: Despite the surge in COVID-19 treatment studies, a consistent proportion continue to exclude pregnant women, with many treatments under evaluation having low or no safety concerns during pregnancy. Urgent inclusion of pregnant women in clinical treatment trials is needed to identify effective COVID-19 treatments for this population.

LANCET GLOBAL HEALTH (2021)

Add to Collection

Letter Virology

Remdesivir for the treatment of COVID-19 in pregnancy

Temi Lampejo

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment

Jiashu Xie et al.

Summary: The study examined the potential of Remdesivir and its parent nucleoside GS-441524 as oral drugs for treating COVID-19. Results showed that Remdesivir had poor stability in vitro, while GS-441524 exhibited better metabolic stability and oral bioavailability, indicating its potential as a promising oral antiviral drug for COVID-19 treatment.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Article Biochemical Research Methods

Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat

Ping Du et al.

Summary: A robust HPLC-MS/MS method was developed to determine Nuc concentrations in rat plasma samples, which was successfully applied in a rat pharmacokinetics study of remdesivir and can serve as a basis for further investigations in patients with COVID-19. The method met the requirements of the FDA guidelines and ensured robustness and reproducibility.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Potency and pharmacokinetics of GS-441524 derivatives against SARS-CoV-2

Daibao Wei et al.

Summary: Nucleoside metabolite GS-441524, an analog of remdesivir, shows potent anti-SARS-CoV-2 efficacy but has poor oral bioavailability in non-human primates. Various GS-441524 analogs with modifications and prodrug forms were developed, with the 7-fluoro analog 3c and certain prodrugs demonstrating moderate to excellent activities and oral bioavailabilities, providing insights for pharmacokinetic optimization.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions

Subrata Deb et al.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2021)

Add to Collection

Article Chemistry, Medicinal

Blood-Placental Barrier Transfers and Pharmacokinetics of Unbound Morphine in Pregnant Rats with Multiple Microdialysis Systems

I-Hsin Lin et al.

Summary: Microdialysis coupled with UHPLC-MS/MS was used to monitor unbound morphine and its metabolites in pregnant rats. The study revealed rapid biotransformation of morphine and partial transfer of morphine and its metabolites across the blood-placental barrier in pregnant rats. This method can be applied to study maternal pharmacokinetics and blood-placental transfer in pregnant rats.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Add to Collection

Article Pharmacology & Pharmacy

A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humans

Patrick O. Hanafin et al.

Summary: The outbreak of SARS-CoV-2 led to the COVID-19 pandemic with millions of confirmed infections and deaths worldwide. Remdesivir has shown effectiveness against coronaviruses, but its distribution to the site of lung infection in humans is unknown. Alternative dosing strategies may be needed to achieve more efficacious concentrations in human lungs.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2021)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit

Duxin Sun

AAPS JOURNAL (2020)

Add to Collection

Article Obstetrics & Gynecology

Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden

Julius Collin et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Calvin J. Gordon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

Richard T. Eastman et al.

ACS CENTRAL SCIENCE (2020)

Add to Collection

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medical Laboratory Technology

Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient

Jean-Claude Alvarez et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Add to Collection

Article Infectious Diseases

Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19

Massimo Tempestilli et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Add to Collection

Review Medicine, General & Internal

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening

Cristina Adriana Dehelean et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020

Laura D. Zambrano et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Review Obstetrics & Gynecology

Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019

Margaux Louchet et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2020)

Add to Collection

Article Medicine, Research & Experimental

Predicting Fraction Unbound in Human Plasma from Chemical Structure: Improved Accuracy in the Low Value Ranges

Reiko Watanabe et al.

MOLECULAR PHARMACEUTICS (2018)

Add to Collection

Article Cell Biology

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Add to Collection

Article Chemistry, Medicinal

Volume of Distribution in Drug Design

Dennis A. Smith et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Add to Collection

Article Anesthesiology

Placental structure, function and drug transfer

Sarah K. Griffiths et al.

BJA EDUCATION (2015)

Add to Collection

Review Microbiology

Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents

Daniel Gonzalez et al.

CLINICAL MICROBIOLOGY REVIEWS (2013)

Add to Collection

Review Chemistry, Medicinal

Plasma Protein Binding: From Discovery to Development

Tonika Bohnert et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.